Arete Wealth Advisors’s Mustang Bio MBIO Stock Holding History

Arete Wealth Advisors’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21	Closed	-$6K	–	718
2023 Q1	$6K	Hold	21	–	–	﹤0.01%	651
2022 Q4	$6.14K	Hold	21	–	–	﹤0.01%	625
2022 Q3	$7K	Buy	+21	New	+$9.73K	﹤0.01%	576
2022 Q2	–	Sell	-21	Closed	-$16K	–	517
2022 Q1	$16K	Hold	21	–	–	﹤0.01%	505
2021 Q4	$26K	Buy	+21	New	+$33.9K	﹤0.01%	499

Other funds holding MBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.3B AUM 18.84% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Arete Wealth Advisors's MBIO Position: Q2 2023 in Review

Arete Wealth Advisors sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 21 shares — an estimated $6K sold.

Arete Wealth Advisors first reported a position in MBIO in Q4 2021 and held it in 5 quarters. The position peaked at $26K in Q4 2021. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

Arete Wealth Advisors reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
Arete Wealth Advisors sold 21 Mustang Bio shares in Q2 2023, an estimated $6K.
Arete Wealth Advisors first reported a position in Mustang Bio in Q4 2021 and held it in 5 quarters.
Arete Wealth Advisors's Mustang Bio position peaked at $26K in Q4 2021.
27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Arete Wealth Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.